Acquisition History / Edwards Lifesciences / Vectorious Medical Technologies
Edwards Lifesciences Acquires Vectorious Medical Technologies
Announced September 4, 2025 — $497M
What happened
Vectorious is an Israeli developer of the V-LAP heart failure monitoring technology. Edwards Lifesciences completed its US$497M acquisition of the company.
- Acquirer
- Edwards Lifesciences
- Target
- Vectorious Medical Technologies
- Announced
- September 4, 2025
- Price
- $497M
- Industry
- Heart failure monitoring devices
- Buyer type
- Strategic acquirer
- Status
- Closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Edwards Lifesciences acquire Vectorious Medical Technologies?
Edwards Lifesciences acquired Vectorious Medical Technologies on September 4, 2025. This was Edwards Lifesciences's 1st publicly tracked acquisition out of 1 we have on record.
How much did Edwards Lifesciences pay for Vectorious Medical Technologies?
Edwards Lifesciences paid $497M for Vectorious Medical Technologies.
What does Vectorious Medical Technologies do?
Vectorious is an Israeli developer of the V-LAP heart failure monitoring technology. Edwards Lifesciences completed its US$497M acquisition of the company.
What other Heart failure monitoring devices companies has Edwards Lifesciences acquired?
Vectorious Medical Technologies is Edwards Lifesciences's only publicly tracked acquisition in Heart failure monitoring devices so far.